Patent classifications
A61M60/32
Sutureless inflow cannula assembly for connecting ventricular assist devices to human circulation
An inflow cannula assembly intended for connecting a ventricular assist device (VAD) to a heart chamber without suturing anastomosis is provided. The inflow cannula assembly includes a deformable flow cannula with funnel-shaped bellmouth intake at a first end and a second end interfaced to the inlet of a VAD with minimal interface discontinuity; also includes is a pair of male and female fasteners that can be screw locked to fix and seal the cannula bellmouth against the endocardium for hemostasis purpose; as well as a VAD coupler and a VAD inlet adapter that enable a quick connection of the cannula with the VAD.
Sutureless inflow cannula assembly for connecting ventricular assist devices to human circulation
An inflow cannula assembly intended for connecting a ventricular assist device (VAD) to a heart chamber without suturing anastomosis is provided. The inflow cannula assembly includes a deformable flow cannula with funnel-shaped bellmouth intake at a first end and a second end interfaced to the inlet of a VAD with minimal interface discontinuity; also includes is a pair of male and female fasteners that can be screw locked to fix and seal the cannula bellmouth against the endocardium for hemostasis purpose; as well as a VAD coupler and a VAD inlet adapter that enable a quick connection of the cannula with the VAD.
PARA-AORTIC BLOOD PUMP DEVICE
A para-aortic blood pump device includes a blood pump, an aortic adapter, a driveline, and a driver. The blood pump includes a blood sac, a pump housing and a pressure sensor, whereas the pressure sensor is installed in the pump housing for monitoring the blood pressure inside the blood pump. The aortic adapter is a T-manifold shaped conduit connected to the blood pump and is used for connecting the blood pump with human aorta to facilitate circulatory support. The driveline allows a pneumatic communication to the blood pump in addition to transmitting the electrical blood pressure signal to the driver. The driver receives and processes the electrical blood pressure signal, decides the timing, speed and duration of blood pump fill and eject actions so as to provide counter-pulsatile circulatory support to assist human circulation.
PARA-AORTIC BLOOD PUMP DEVICE
A para-aortic blood pump device includes a blood pump, an aortic adapter, a driveline, and a driver. The blood pump includes a blood sac, a pump housing and a pressure sensor, whereas the pressure sensor is installed in the pump housing for monitoring the blood pressure inside the blood pump. The aortic adapter is a T-manifold shaped conduit connected to the blood pump and is used for connecting the blood pump with human aorta to facilitate circulatory support. The driveline allows a pneumatic communication to the blood pump in addition to transmitting the electrical blood pressure signal to the driver. The driver receives and processes the electrical blood pressure signal, decides the timing, speed and duration of blood pump fill and eject actions so as to provide counter-pulsatile circulatory support to assist human circulation.
Implantable co-pulsatile epi-ventricular circulatory support system with sutureless flow cannula assembly
An implantable circulatory support system, configured to connect a ventricular chamber of a heart, including a valveless displacement blood pump, a deformable polymeric flow cannula, a pair of male and female fasteners, a coupler, a driveline assembly, and a co-pulsatile driver. Forward and backward flow communication between the blood pump and the heart chamber is accomplished using the present flow cannula invention which is anastomosed to the heart chamber in a sutureless manner. When providing circulatory support, the co-pulsatile driver ejects blood out of the blood pump during systolic ventricular contraction and fills the blood pump with blood during diastolic ventricular relaxation.
Implantable co-pulsatile epi-ventricular circulatory support system with sutureless flow cannula assembly
An implantable circulatory support system, configured to connect a ventricular chamber of a heart, including a valveless displacement blood pump, a deformable polymeric flow cannula, a pair of male and female fasteners, a coupler, a driveline assembly, and a co-pulsatile driver. Forward and backward flow communication between the blood pump and the heart chamber is accomplished using the present flow cannula invention which is anastomosed to the heart chamber in a sutureless manner. When providing circulatory support, the co-pulsatile driver ejects blood out of the blood pump during systolic ventricular contraction and fills the blood pump with blood during diastolic ventricular relaxation.
Blood pump
A blood pump comprises a pump casing having a blood flow inlet and a blood flow outlet, and an impeller arranged in said pump casing so as to be rotatable about an axis of rotation. The impeller has blades sized and shaped for conveying blood from the blood flow inlet to the blood flow outlet. The blood pump also has an outflow cannula having an upstream end portion, a downstream end portion and an intermediate portion extending between the upstream end portion and the downstream end portion. The upstream end portion of the outflow cannula is connected to the pump casing such that blood is conveyed from the blood flow outlet of the pump casing into and through the intermediate portion of the outflow cannula towards the downstream end portion of the outflow cannula, wherein the downstream end portion has a blood flow outlet through which blood can exit the outflow cannula. At least a portion of the intermediate portion of the outflow cannula has an outer diameter that is larger than an outer diameter of the pump casing.
SYSTEMS AND METHODS FOR CUSTOMIZED PULSATILE PERFUSION CONTROL
Aspects of the present disclosure generally relate to systems and methods for perfusion, and more specifically, for pulsatile blood perfusion based on a measured pressure waveform. One example method generally includes receiving, via a graphical user interface presented to a user, datapoints indicating a waveform; receiving one or more parameters associated with blood perfusion; generating an offset removed waveform based on the datapoints, the offset removed waveform having a physiological offset removed; converting the offset-removed waveform to a voltage waveform based on the one or more parameters; and operating, via the voltage waveform, a pump to provide blood in a perfusion system. The aspects described herein are applicable for any suitable perfusion environment, such as extracorporeal perfusion or isolated organ perfusion.
SYSTEMS AND METHODS FOR CUSTOMIZED PULSATILE PERFUSION CONTROL
Aspects of the present disclosure generally relate to systems and methods for perfusion, and more specifically, for pulsatile blood perfusion based on a measured pressure waveform. One example method generally includes receiving, via a graphical user interface presented to a user, datapoints indicating a waveform; receiving one or more parameters associated with blood perfusion; generating an offset removed waveform based on the datapoints, the offset removed waveform having a physiological offset removed; converting the offset-removed waveform to a voltage waveform based on the one or more parameters; and operating, via the voltage waveform, a pump to provide blood in a perfusion system. The aspects described herein are applicable for any suitable perfusion environment, such as extracorporeal perfusion or isolated organ perfusion.
METHOD OF REDUCING MICROVASCULAR OBSTRUCTIONS BY PROVIDING VENTRICULAR SUPPORT
The disclosed technology relates to methods of preventing or limiting effects of heart failure in a human patient that has sustained acute myocardial infarction. The method includes determining that the patient is exhibiting acute myocardial infarction, inserting a transvalvular pump at least partially into a heart of the patient, and operating the transvalvular pump to cause blood to flow at a rate of at least 2.5 L/min for at least a support period. The method further includes performing a reperfusion of the patient's heart to restore blood flow to the heart after at least the support period has ended and reducing the amount of tissue actually comprising microvascular obstruction (MVO) of tissue that is at risk of MVO by approximately 20%.